Literature DB >> 11122854

Cancer in the elderly: are we ready?

D Khayat1, G Auclerc.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11122854     DOI： 10.1007/s11912-000-0017-9

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  5 in total

1.  Underrepresentation of patients 65 years of age or older in cancer-treatment trials.

Authors:  L F Hutchins; J M Unger; J J Crowley; C A Coltman; K S Albain
Journal:  N Engl J Med       Date:  1999-12-30       Impact factor: 91.245

Review 2.  Cancer in older persons. Magnitude of the problem--how do we apply what we know?

Authors:  R Yancik; L A Ries
Journal:  Cancer       Date:  1994-10-01       Impact factor: 6.860

Review 3.  Clinical aspects of cancer in the elderly. Treatment decisions, treatment choices, and follow-up.

Authors:  R J McKenna
Journal:  Cancer       Date:  1994-10-01       Impact factor: 6.860

4.  Cancer treatment and age: patient perspectives.

Authors:  P A Newcomb; P P Carbone
Journal:  J Natl Cancer Inst       Date:  1993-10-06       Impact factor: 13.506

5.  Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance.

Authors:  R S Gelman; S G Taylor
Journal:  J Clin Oncol       Date:  1984-12       Impact factor: 44.544
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.